Longevity News

Von Willebrand factor A1 blockade prevents platelet-mediated sustained occlusion for the treatment of arterial thrombosis

Source: Nature - Biotechnology • Published: 11 Jul 2026, 00:00

Von Willebrand factor A1 blockade prevents platelet-mediated sustained occlusion for the treatment of arterial thrombosis

Skip to main content Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the s...

Key Takeaways
  • Please note there may be errors present which affect the content, and all legal disclaimers apply
  • Arterial thrombosis is a leading cause of death and disability worldwide
  • Aiming to understand VWF-mediated recanalization (vessel reopening)
Read Original Source